13h
FNIH Announces FDA Qualification of First Surrogate Endpoint for Use in Osteoporosis Clinical Trials
FDA has qualified the first surrogate endpoint for bone fractures in anti-osteoporosis drug trials for at-risk ...
Curvebeam AI reckons the shortest path to better surgery starts with one scan, one visit and patients on their feet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback